Article Information
History
- March 9, 2021.
Article Versions
- Version 1 (January 27, 2021 - 01:42).
- Version 2 (February 1, 2021 - 19:24).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- F. van Dijk1,2,
- S. Song1,3,
- G.W.A van Eck1,
- X. Wu1,2,
- I.S.T. Bos1,
- D.H.A. Boom4,
- I.M. Kooter4,
- D.C.J. Spierings5,
- R. Wardenaar5,
- M. Cole6,
- A. Salvati7,
- R. Gosens1,2 and
- B.N. Melgert1,2,*
- 1Groningen Research Institute for Pharmacy, Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands
- 2Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
- 3Groningen Research Institute for Pharmacy, Department of Chemical and Pharmaceutical Biology, University of Groningen, Groningen, the Netherlands
- 4The Netherlands Organization for Applied Scientific Research, TNO, Utrecht, the Netherlands
- 5European Research Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
- 6Plymouth Marine Laboratory, Plymouth, United Kingdom
- 7Groningen Research Institute for Pharmacy, Department of Nanomedicine & Drug Targeting, University of Groningen, Groningen, the Netherlands
- ↵*Corresponding author: Prof Dr Barbro N. Melgert, Groningen Research Institute of Pharmacy, Department of Molecular Pharmacology, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen, the Netherlands, b.n.melgert{at}rug.nl